Trade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreTrade Setup Buy Target $2.12 Sell Target $2.27 Companhia Siderúrgica Nacional operates as an integrated steel producer in Brazil and Latin America. The company operates in five segments: Steel, Mining, Cement, Logistics, and Energy. It offers flat steel products, such as slabs.
Read MoreTrade Setup Buy Target $3.24 Sell Target $3.45 ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Innovative Ag Solutions (IAS). The Industrial Products segment produces bromine out of a solution that is a by-product of the […]
Read MorePlus, Goldman Sachs and Citi issued new forecasts for the market and economy, Regeneron is beginning a phase 3 trial of its coronavirus antibody cocktail, the FDA issued emergency use authorization for Becton Dickinson’s 15-minute coronavirus test, and Uber has officially agreed to acquire Postmates.
Read MoreBuy Price: $13.00 or better Sell Price: TradersPro Sell Signal Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of renal therapeutics for patients with kidney diseases. The company’s lead product candidate includes Auryxia, a ferric citrate to control the serum phosphorus levels in adult patients with chronic kidney disease (CKD), on […]
Read MoreIf you’re like me, you’re undoubtedly getting tired of the seemingly endless discussion and examination of COVID-19. Latest infection numbers, speculation about vaccine development progress, whether governments will reimpose restrictions or mandate common sense measures like wearing masks in public – let’s face it, it gets tiresome to be confronted with what appears to be […]
Read More